Implementing Physician Education to Increase Lung Cancer Screening Uptake

Overview

Journal Lung Cancer Manag

Date 2023 May 1

PMID 37122495

Authors

Coral Olazagasti

Nagashree Seetharamu

Nina Kohn

David Steiger

Affiliations

Soon will be listed here.

Abstract

Aim: Lung cancer (LC) is the leading cause of cancer-related deaths worldwide. The US Preventive Services Task Force and National Comprehensive Cancer Network recommend annual low-dose computed tomography (LDCT) for eligible adults. We conducted a study to assess physician LDCT referral patterns.

Methods: The study was divided into a pre-, intervention, and post-intervention periods. The intervention was a LC screening educational series. We evaluated rates of LDCT screening referrals during pre- and post-intervention periods.

Results: In the pre-intervention period, 75 patients fulfilled US Preventive Services Task Force and/or National Comprehensive Cancer Network criteria and 27% underwent LDCT. In the post-intervention period, 135 patients fulfilled either screening criteria of whom 61.5% underwent LDCT.

Conclusion: In our study, educational lectures improved compliance significantly and should be used as tool for primary care providers to effectively increase LDCT screening referrals.

References

Aberle D, Adams A, Berg C, Black W, Clapp J, Fagerstrom R . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409. PMC: 4356534. DOI: 10.1056/NEJMoa1102873. View

Eberth J, McDonnell K, Sercy E, Khan S, Strayer S, Dievendorf A . A national survey of primary care physicians: Perceptions and practices of low-dose CT lung cancer screening. Prev Med Rep. 2018; 11:93-99. PMC: 6030390. DOI: 10.1016/j.pmedr.2018.05.013. View

Rami-Porta R, Ball D, Crowley J, Giroux D, Jett J, Travis W . The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol. 2007; 2(7):593-602. DOI: 10.1097/JTO.0b013e31807a2f81. View

Oken M, Hocking W, Kvale P, Andriole G, Buys S, Church T . Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011; 306(17):1865-73. DOI: 10.1001/jama.2011.1591. View

Ersek J, Eberth J, McDonnell K, Strayer S, Sercy E, Cartmell K . Knowledge of, attitudes toward, and use of low-dose computed tomography for lung cancer screening among family physicians. Cancer. 2016; 122(15):2324-31. DOI: 10.1002/cncr.29944. View

Williams R, Li T, Luta G, Wang M, Adams-Campbell L, Meza R . Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data. Cancer. 2022; 128(9):1812-1819. PMC: 9007861. DOI: 10.1002/cncr.34098. View

Henschke C, McCauley D, Yankelevitz D, Naidich D, McGuinness G, Miettinen O . Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 1999; 354(9173):99-105. DOI: 10.1016/S0140-6736(99)06093-6. View

Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P . Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest. 2004; 126(1):114-21. DOI: 10.1378/chest.126.1.114. View

Goldstraw P, Crowley J, Chansky K, Giroux D, Groome P, Rami-Porta R . The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007; 2(8):706-14. DOI: 10.1097/JTO.0b013e31812f3c1a. View

10.

Moyer V . Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 160(5):330-8. DOI: 10.7326/M13-2771. View

11.

Kale M, Wisnivesky J, Taioli E, Liu B . The Landscape of US Lung Cancer Screening Services. Chest. 2018; 155(5):900-907. PMC: 6533452. DOI: 10.1016/j.chest.2018.10.039. View

12.

Wood D, Kazerooni E, Aberle D, Berman A, Brown L, Eapen G . NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022. J Natl Compr Canc Netw. 2022; 20(7):754-764. DOI: 10.6004/jnccn.2022.0036. View

13.

Zahnd W, Eberth J . Lung Cancer Screening Utilization: A Behavioral Risk Factor Surveillance System Analysis. Am J Prev Med. 2019; 57(2):250-255. DOI: 10.1016/j.amepre.2019.03.015. View

14.

Duong D, Shariff-Marco S, Cheng I, Naemi H, Moy L, Haile R . Patient and primary care provider attitudes and adherence towards lung cancer screening at an academic medical center. Prev Med Rep. 2017; 6:17-22. PMC: 5304233. DOI: 10.1016/j.pmedr.2017.01.012. View

15.

Jemal A, Fedewa S . Lung Cancer Screening With Low-Dose Computed Tomography in the United States-2010 to 2015. JAMA Oncol. 2017; 3(9):1278-1281. PMC: 5824282. DOI: 10.1001/jamaoncol.2016.6416. View

16.

Melamed M, Flehinger B, Zaman M, Heelan R, Perchick W, Martini N . Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest. 1984; 86(1):44-53. DOI: 10.1378/chest.86.1.44. View

17.

Zhao Y, Xie X, de Koning H, Mali W, Vliegenthart R, Oudkerk M . NELSON lung cancer screening study. Cancer Imaging. 2011; 11 Spec No A:S79-84. PMC: 3266562. DOI: 10.1102/1470-7330.2011.9020. View

18.

Wood D, Kazerooni E, Baum S, Eapen G, Ettinger D, Hou L . Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018; 16(4):412-441. PMC: 6476336. DOI: 10.6004/jnccn.2018.0020. View